China tests new stealth fighter; eyes export sales

December 26, 2016

Beijing, Dec 26: China has tested an improvised version of its stealth fighter and plans to sell it at half the price of the US variant to break Western monopoly over the high-tech aircraft, which will have strategic implications for India as Pakistan has already shown interest in acquiring it.plane

An improved version of China's fifth-generation FC-31 Gyrfalcon stealth fighter jet has conducted its maiden flight last week in Shenyang, capital of Liaoning province, state-run China Daily reported today.

Previously known as the J-31, the twin engine, radar evading aircraft is still under development by Shenyang Aircraft Corp, part of the Aviation Industry Corp of China, (AVIC), it said.

The Chinese stealth aircraft have strategic significance for India as besides China, Pakistan - which is producing JF-17 Thunder fighter along with Beijing - has already evinced interest in acquiring China's stealth fighter.

India is yet to have stealth aircraft in its arsenal. AVIC displayed a large-scale model of the FC-31 at the 14th Dubai Airshow in the UAE in November, 2015.

Specifications supplied by AVIC show the jet has a maximum takeoff weight of 28 metric tonnes, a flight radius of 1,250 kms and a top speed of Mach 1.8, or 1.8 times the speed of sound.

It can carry eight tonnes of weapons. The plane can hold six missiles in its internal weapons bay and another six under its wings, AVIC said.

The first test flight of the FC-31's second prototype took place on Friday at Shenyang Aircraft Corp, four years after the first prototype took to the skies, the Daily quoted officials as saying.

The report also said fifth-generation fighters are the most advanced available. Fu Qianshao, an aircraft expert with the PLA Air Force, said the new FC-31 has state-of-the-art instruments such as its electro-optical targeting system and helmet-mounted display and sight system.

The new FC-31 seems to have better stealth capabilities, improved electronic equipment and a larger payload capacity, said Wu Peixin, an aviation industry observer in Beijing said.

"Compared with the first FC-31, there are a lot of improvements on the second prototype. Changes were made to the airframe, wings and vertical tails, which make it leaner, lighter and more manoeuvrable," he said.

AVIC wants to use the FC-31 to capture market share at home and abroad but the company is making a big push to attract foreign buyers with its medium-sized stealth combat planes, he said.

Li Yuhai, deputy general manager of AVIC, previously said AVIC plans to use the FC-31 to "put an end to some nations' monopolies on the fifth-generation fighter jet" and this plane "is able to compete with any other aircraft of its kind".

"I believe the aircraft will have bright prospects in the market. Based on my experience and knowledge, I presume its price will be around USD 70 million, about half that of the US' Lockheed Martin F-35 Lightning II," Fu said.

"Moreover, the fourth-generation Euro fighter Typhoon and Dassault Rafale fighter jets are priced at about USD 100 million. All of these mean you can spend a lot less money to get an advanced, fifth-generation stealth combat plane," Fu told the Daily.

The only fifth-generation fighter jet currently available in the market is the US' F-35 Lightning II, but the US sells it only to allies.

Following the Friday test flight, aviation enthusiasts posted pictures on Chinese websites, showing what they said was the second prototype in flight.

The FC-31 was unveiled in October, 2012, when the first prototype made its maiden flight, becoming the country's second fifth-generation fighter jet following the J-20, which conducted its first flight in January, 2011.

Deliveries of the J-20 to the People's Liberation Army Air Force have started.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 12,2020

May 12: Gunmen stormed a hospital on Tuesday in an ongoing attack in the Afghan capital Kabul, as a suicide blast killed 15 people at a funeral in the country's restive east.

Special forces rescued 80 people including mothers and babies from the Kabul hospital after three gunmen launched a morning assault, killing at least four people, the interior ministry said in a statement.

Heavily armed forces were seen carrying babies wrapped in blankets away from the scene, as the clearance operation continued.

The facility, which has a large maternity ward, is located in the west of the city, home to the capital's minority Shiite Hazara community -- a frequent target of Sunni militants from the Islamic State group.

The flare-up in violence comes as Afghanistan grapples with myriad crises including a rise in militant operations across the country and a surge in coronavirus infections.

A paediatrician who fled the hospital told AFP he heard a loud explosion at the entrance of the building.

"The hospital was full of patients and doctors, there was total panic inside," he said, asking not to be named.

The maternity services at the hospital are supported by humanitarian organisation Doctors Without Borders (MSF).

"Hospitals and health workers must not be attacked. We call on all sides to stop attacking hospitals and health workers," said deputy health minister in the city, Waheed Majroh.

Around an hour later, a suicide bomber killed at least 15 people at the funeral of a local police commander in the country's eastern Nangarhar province, according to provincial spokesman Ataullah Khogyani.

The attacker detonated his explosives in the middle of the ceremony.

Zaher Adel, spokesman for the government hospital in Jalalabad, earlier said 12 bodies had arrived from the blast site and more than 50 people were being treated for injuries.

Amir Mohammad, who was wounded in the blast, said thousands of people had gathered for the funeral, an event which often draws huge crowds in Afghanistan.

The violence comes just a day after four roadside bombs exploded in a northern district of Kabul, wounding four civilians including a child.

The bombings were later claimed by the Islamic State group, according to the SITE intelligence group.

They were just the latest in a string of IS attacks on the capital.

In March, at least 25 people were killed by a gunman at a Sikh temple in Kabul, which was later claimed by the group.

IS is also responsible for an infamous attack in March 2017 on one of the country's largest hospitals, when gunmen disguised as doctors stormed the Kabul building and killed dozens.

In recent months, the jihadist group has suffered mounting setbacks after being hunted by US and Afghan forces as well as Taliban offensives targeting their fighters, but it still retains the ability to launch major assaults on urban centres.

The Taliban have largely refrained from launching large attacks on Afghan cities since February when they signed a landmark withdrawal deal with the US meant to pave the way for peace talks with the Kabul government.

Under the agreement, the Taliban promised not to target forces from the US-led coalition, but made no such pledge toward Afghan troops and have stepped up attacks in the provinces.

The Taliban have denied involvement in both of Tuesday's attacks.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 25,2020

Beijing:  Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 26,2020

Tokyo, Feb 26: Two more Indians onboard quarantined cruise ship -- Diamond Princess -- were tested positive for novel coronavirus, the Indian embassy here said on Tuesday, adding that those Indians not infected by the virus will be repatriated to the homeland on February 26.

A total of 16 Indian nationals onboard the luxury ship -- quarantined off the coast of Japan since February 5 -- have been tested positive for coronavirus so far, the embassy informed.

"A chartered flight is being arranged to repatriate Indian nationals onboard #DiamondPrincess, provided they have (a) consented; (b) not tested positive for #COVID19; (c) cleared by the medical team. An email advisory to this effect, with details, has been sent to them," the embassy tweeted.

The repatriation of the Indian nationals will be facilitated by the Indian government.

"PCR test results for ALL Indian nationals declared-02 more Indians tested positive to #COVID19, taking the total to 16. Those fulfilling conditions and consenting to repatriation to India on 26 Feb being facilitated by the Indian Government. Details shared with them," the following tweet read.

A total of 138 Indians, including 132 crew and 6 passengers, were among the 3,711 people on board the luxury cruise ship which was quarantine off Japan on February 5 after it emerged that a former passenger had tested positive for the virus.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.